Canine lymphoma, which is one of the most common malignancies diagnosed in dogs, is typically seen as a systemic disease that often involves the lymph nodes, liver, and spleen, and may include the bone marrow and non-lymphoid sites. Since the disease is so prevalent, research is constantly ongoing to advance diagnosis and treatment. The following article details common diagnostic modalities, new treatment options, and current research on canine lymphoma.
Canine lymphoma diagnosis
IDEXX’s Nu.Q Canine Cancer test is helpful for screening high-risk dogs for lymphoma. The test is an enzyme-linked immunosorbent assay (ELISA) that detects nucleosomes released when cells die and has an overall 77% lymphoma detection rate. Other common diagnostic tests used include:
Canine lymphoma treatment
Chemotherapy is the most effective therapy for most canine lymphoma types. The most recent Food and Drug Administration (FDA)-approved specialized oncology therapeutics for dogs include:
Canine lymphoma research
Numerous current studies to learn more about this relevant and concerning disease include:
List
Add
Please enter a comment